ADAGE CAPITAL PARTNERS GP L.L.C. 13D and 13G filings for Inozyme Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-07 07:46 am Purchase | 2023-12-31 | 13G | Inozyme Pharma, Inc. INZY | ADAGE CAPITAL PARTNERS GP L.L.C. | 5,537,500 8.970% | 2,437,362 (+78.62%) | Filing |
| 2023-02-09 11:43 am Purchase | 2022-12-31 | 13G | Inozyme Pharma, Inc. INZY | ADAGE CAPITAL PARTNERS GP L.L.C. | 3,100,138 7.670% | 1,501,110 (+93.88%) | Filing |
| 2022-02-10 09:22 am Purchase | 2021-12-31 | 13G | Inozyme Pharma, Inc. INZY | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,599,028 6.760% | 310,356 (+24.08%) | Filing |
| 2021-05-10 4:05 pm Purchase | 2021-04-29 | 13G | Inozyme Pharma, Inc. INZY | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,288,672 5.490% | 1,288,672 (New Position) | Filing |